Optimizing nutrition support for patients with severe stroke
Trophic Enteral Feeding Combined With Supplemental Parenteral Nutrition Treatment in Patients With Severe Stroke (OPENS-2): a Multicentre, Prospective, Randomised, Open-label, Blinded-endpoint Trial
This study is testing which type of nutrition support helps patients with severe strokes reduce the risk of pneumonia and improve their recovery during the first week after their stroke.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Enrollment | 546 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Xijing Hospital Academic / other |
| Locations | 30 sites (Chongqing, Chongqing Municipality and 29 other locations) |
| Trial ID | NCT05998902 on ClinicalTrials.gov |
What this trial studies
This study aims to determine the most effective nutrition support strategy for patients with acute severe stroke to reduce the risk of post-stroke pneumonia (PSP) and improve overall prognosis. It will enroll 546 patients who will be randomly assigned to receive either full enteral feeding or a combination of trophic enteral feeding and supplemental parenteral nutrition for 7 days. The study focuses on addressing the complications associated with aspiration and poor nutritional status in severe stroke patients, particularly during the critical first week after the stroke event.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a confirmed diagnosis of acute severe stroke and a need for nutritional support.
Not a fit: Patients with contraindications for enteral nutrition or those with a life expectancy of less than 7 days may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of pneumonia and improve recovery outcomes for patients with severe stroke.
How similar studies have performed: Previous studies have indicated that alternative nutritional strategies can reduce complications in stroke patients, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age≥18 years 2. Definite diagnosis of acute stroke (GCS ≤12 or NIHSS≥11) 3. The randomized nutritional treatment could be initiated up to 72 hours after symptom onset. 4. Any cases of profiles #3 through 5 in Water Swallowing Test or with disorder of consciousness. 5. Plan to receive nutritional support treatment for at least 7 days. 6. Informed consent. Exclusion Criteria: 1. Receiving parenteral nutrition support 2. Contraindications of enteral nutrition 3. Complicated with the disease which only have life expectancy \< 7 days 4. Admission with infection signs 5. Dementia or severe disability (mRS\>4) before stroke 6. Antibiotics were used within the previous 7 days 7. Subarachnoid hemorrhage, cerebral arteriovenous malformation 8. Presence of coexisting medical conditions that could interfere with outcome assessment and/or follow-up (a. advanced cancer; b. severe pulmonary dysfunction \[forced expiratory volume in 1 second \< 50% or/and moderate to severe acute lung injury (PaO2/FiO2)\<200mmHg\]; c. cardiac insufficiency (NYHA class \> I; cardiac structural and/or functional abnormalities such as EF\< 50%, abnormal cardiac chamber enlargement, moderate/severe ventricular hypertrophy, or moderate/severe valvular stenosis); d. Severe liver failure \[Child-Pugh score≥7\]; e. Severe renal failure \[glomerular filtration rate ≤30mL/min or serum creatinine ≥4mg/dL\] 9. Currently participating in other clinical trial 10. Pregnant woman 11. Patient who is considered highly likely not to adhere to the study treatment or follow-up protocol.
Where this trial is running
Chongqing, Chongqing Municipality and 29 other locations
- Chongqing University Three Gorges Hospital — Chongqing, Chongqing Municipality, China (Recruiting)
- Daping Hospital, The Third Military Medical University — Chongqing, Chongqing Municipality, China (Recruiting)
- Gansu Provincal Central Hospital — Lanzhou, Gansu, China (Recruiting)
- Nanfang Hospital, Southern Medical University — Guangzhou, Guangdong, China (Not_yet_recruiting)
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine — Guangzhou, Guangdong, China (Recruiting)
- The Affiliated Hospital of Guizhou Medical University — Guiyang, Guizhou, China (Recruiting)
- First Affiliated Hospital of Zhengzhou University — Zhengzhou, Henan, China (Recruiting)
- Tongji Hospital — Wuhan, Hubei, China (Recruiting)
- The First Hospital of Changsha City — Changsha, Hunan, China (Not_yet_recruiting)
- The Second Affiliated Hospital of Nanchang University — Nanchang, Jiangxi, China (Recruiting)
- General Hospital of Ningxia Medical University — Yinchuan, Ningxia, China (Recruiting)
- Shaanxi Second Provincal People's Hospital — Xi'an, Shaanxi, China (Recruiting)
- Tangdu Hospital — Xi'an, Shaanxi, China (Not_yet_recruiting)
- The first affiliated hospital of Xi'an Jiaotong University — Xi'an, Shaanxi, China (Recruiting)
- Xi'an Central Hospital — Xi'an, Shaanxi, China (Not_yet_recruiting)
- Department of Neurology, Xijing Hospital — Xi'an, Shaanxi, China (Recruiting)
- Shannxi Provincal People's Hospital — Xi'an, Shaanxi, China (Not_yet_recruiting)
- The First Affiliated Hospital of Xi'an Medical University — Xi'an, Shaanxi, China (Recruiting)
- Xi'an Gaoxin Hospital — Xi'an, Shaanxi, China (Recruiting)
- Xi'an No.3 Hospital — Xi'an, Shaanxi, China (Recruiting)
- Xianyang Hospital, Yan'an University — Xianyang, Shaanxi, China (Recruiting)
- The First People's Hospital of Xianyang — Xianyang, Shaanxi, China (Recruiting)
- Yulin No.1 Hospital — Yulin, Shaanxi, China (Not_yet_recruiting)
- Yulin No.2 Hospital — Yulin, Shaanxi, China (Not_yet_recruiting)
- Qilu Hospital of Shangdong University — Jinan, Shandong, China (Not_yet_recruiting)
- The PLA 960 Hospital — Jinan, Shandong, China (Recruiting)
- The Second Hospital of Shandong University — Jinan, Shandong, China (Recruiting)
- Liaocheng People's Hospital — Liaocheng, Shandong, China (Recruiting)
- People's Hospital of Xinjiang Uygur Autonomous Region — Ürümqi, Xinjiang, China (Recruiting)
- The Second Affiliated Hospital of Xinjiang Medical University — Ürümqi, Xinjiang, China (Recruiting)
Study contacts
- Study coordinator: Wen Jiang, Ph.D
- Email: jiangwen@fmmu.edu.cn
- Phone: 86-029-84771319
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.